Saffron Walden, United Kingdom

Paolo Ricci

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sitryx Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Ricci. Retrieved from https://idiyas.com/inventor/paolo-ricci-034agymj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paolo Ricci: Innovator in Compound Development

Introduction

Paolo Ricci is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of compound development, showcasing his expertise through his innovative work.

Latest Patents

Ricci holds 1 patent related to compounds of formula (I) and its associated aspects. This invention highlights his commitment to advancing scientific knowledge and practical applications in his field.

Career Highlights

Paolo Ricci is currently employed at Sitryx Therapeutics Limited, where he continues to push the boundaries of innovation. His work at the company reflects his dedication to developing new therapeutic solutions.

Collaborations

Throughout his career, Ricci has collaborated with talented individuals such as Alessandro Mazzacani and Paulette Greenidge. These partnerships have enriched his work and contributed to the success of his projects.

Conclusion

Paolo Ricci is a distinguished inventor whose work in compound development has made a significant impact. His contributions to the field and collaborations with other professionals underscore his importance in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…